Skip to main content
NOCIL Ltd logo

NOCIL Ltd — Investor Relations & Filings

Ticker · NOCIL ISIN · INE163A01018 LEI · 335800E78TMI5P232Q87 BSE.NS Manufacturing
Filings indexed 1,738 across all filing types
Latest filing 2020-01-30 Regulatory Filings
Country IN India
Listing BSE.NS NOCIL

About NOCIL Ltd

https://www.nocil.com

NOCIL Ltd specializes in the manufacture and distribution of a comprehensive range of rubber chemicals. The product portfolio includes accelerators, antioxidants, pre-vulcanization inhibitors, and post-vulcanization stabilizers, which are critical components in the vulcanization process. These products enhance the durability, heat resistance, and performance of rubber compounds. The company primarily serves the global tire manufacturing sector alongside diverse non-tire applications, including automotive parts, footwear, and industrial rubber goods. Leveraging advanced manufacturing facilities and dedicated research and development centers, the organization focuses on process innovation and quality assurance. It maintains long-term partnerships with major global manufacturers, providing technical expertise and specialized chemical solutions to support the production of high-performance rubber materials.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2020-01-30 English
Unaudited Financial Results (stand alone and consolidated) for the Quarter ended on 31st December 2019 are attached.
Regulatory Filings
2020-01-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing them about an upcoming conference call to discuss the operational and financial performance for the quarter and nine months ended December 31, 2019. It references SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and provides details about the call, including date, time, and participants. The document does not contain actual financial data or detailed financial analysis but serves as an announcement of the conference call event. Therefore, it fits the category of a Call Transcript announcement or invitation rather than the transcript itself. Given the content and purpose, the most appropriate classification is 'Call Transcript' (CT) as it relates to the earnings call event notification.
2020-01-28 English
Intimation of Conference Call under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Call Transcript Classification · 95% confidence The document is a formal notification addressed to stock exchanges about an upcoming conference call to discuss the operational and financial performance for the quarter and nine months ended December 31, 2019. It references SEBI (Listing Obligations and Disclosure Requirements) regulations and provides details about the call, including date, time, and participants. The document does not contain actual financial data or detailed financial analysis but serves as an announcement of the conference call event. Therefore, it fits the category of a Call Transcript announcement or invitation rather than the transcript itself. Given the nature of the document as an invitation/intimation for a conference call, the appropriate classification is Call Transcript (CT).
2020-01-28 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a letter dated January 27, 2020, addressed to the National Stock Exchange of India. It informs about an additional agenda item for a Board Meeting scheduled on January 30, 2020. The agenda includes approval of unaudited financial results for the quarter and nine months ending December 31, 2019, and consideration of a proposal for amalgamation of promoter group companies with the company. The document is a notification about an upcoming Board Meeting and its agenda, not the actual financial results or amalgamation approval. It does not contain financial statements or detailed financial analysis. The document length is 4527 characters, which is relatively short and more consistent with an announcement or notification rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement informing the stock exchange about the Board Meeting agenda and related corporate actions.
2020-01-27 English
Additional Agenda to be considered in the Board Meeting to be held on Thursday, January 30, 2020
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges about an additional agenda item for an upcoming Board meeting. The agenda concerns the proposal of amalgamation of promoter group companies with the company through a Scheme of Amalgamation. The document is dated January 27, 2020, and is signed by the Company Secretary. It does not contain financial statements, detailed financial analysis, or full report content. Instead, it is an announcement of a board meeting agenda item related to corporate restructuring. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not qualify as a full M&A filing or merger proxy statement, nor is it a full report or earnings release. The document length is short (1716 characters), and it is clearly an announcement rather than a report or presentation.
2020-01-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.